CD56-Enriched Donor Lymphocyte Infusion
IIT2017-03-Merin-HaploBFR
Phase 1 mab completed
Quick answer
CD56-Enriched Donor Lymphocyte Infusion for Multiple Myeloma is a Phase 1 program (mab) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Indication
- Multiple Myeloma
- Phase
- Phase 1
- Modality
- mab
- Status
- completed